Retour aux projets

25383.1 PFLS-LS

25383.1 PFLS-LS

Résumé

High-content screening-compatible in vitro model for Alzheimer's disease in 3DProSeedTM microtiter plate and innovations in the 3DProSeedTM manufacturing technology.

Textes supplémentaires

Abstract

A new assay concept for Alzheimer#s disease will be investigated in one part of the proposed project. The assay concept will be based on the innovative 3DProSeed technology enabling the sequential seeding of iPSC-derived neurons and glia cells within the same pre-assembled hydrogel. The other part of the project will be devoted to the development of 3DProSeed hydrogel production methods in order to meet the high reproducibility requirements of the industry to adopt 3D cell culture products.

Participants

Benjamin Simona

Wirtschaftspartner

simona@ectica-technologies.com

Ectica Technologies AG Benjamin Simona ETZ F76, Gloriastrasse 35 8092 Zürich ZH CH

Martin Ehrbar

Kontaktperson

martin.ehrbar@usz.ch

USZ Universitätsspital Zürich Martin Ehrbar Schmelzbergstrasse 12 8091 Zürich ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2017-03-31
Date de fin
2019-02-28
Coûts totaux approuvés
CHF 324167.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%